Medicare's CAR-T Policy Should Encompass Future Uses, Sites of Care – BIO

Product developers worry coverage might not extend beyond current indications and use in hospitals, based on the draft national coverage determination released by the Centers for Medicare and Medicaid Services.

DNA

More from Market Access

More from Pink Sheet